Zephyrus Innovations announces US FDA approval for its Aeroject™ 3ml safety syringe
- Aeroject™ 3ml safety syringe is a single-use, affordable, first generation syringe
- Aeroject™ has a permanently attached needle system, which upon retraction, fully encases the needle, preventing needle reuse and accidental needlestick
- The ultra-low wasted space syringes allow for the maximum number of doses to be administered per vial, lowering costs
16 February 2023 – Vancouver, Canada: Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes and Closed System Transfer Devices (CSTDs), today announces that it has received its first product 510(k) Marketing Approval from the US Food and Drug Administration (“FDA”) for its Aeroject™ 3ml safety syringe.
